191 related articles for article (PubMed ID: 19690146)
21. Heat shock protein 90 inhibitor regulates necroptotic cell death via down-regulation of receptor interacting proteins.
Park SY; Shim JH; Chae JI; Cho YS
Pharmazie; 2015 Mar; 70(3):193-8. PubMed ID: 25980180
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 90 as a molecular target for therapy in oral squamous cell carcinoma: Inhibitory effects of 17‑DMAG and ganetespib on tumor cells.
Shiraishi N; Onda T; Hayashi K; Onidani K; Watanabe K; Sekikawa S; Shibahara T
Oncol Rep; 2021 Feb; 45(2):448-458. PubMed ID: 33416122
[TBL] [Abstract][Full Text] [Related]
23. Inhibitor of heat-shock protein 90 enhances the antitumor effect of DNA vaccine targeting clients of heat-shock protein.
Lin CC; Tu CF; Yen MC; Chen MC; Hsieh WJ; Chang WC; Chang WT; Lai MD
Mol Ther; 2007 Feb; 15(2):404-10. PubMed ID: 17235320
[TBL] [Abstract][Full Text] [Related]
24. 17-Dimethylaminoethylamino-17-demethoxygeldanamycin attenuates inflammatory responses in experimental stroke.
Qi J; Han X; Liu HT; Chen T; Zhang JL; Yang P; Bo SH; Lu XT; Zhang J
Biol Pharm Bull; 2014; 37(11):1713-8. PubMed ID: 25366476
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluoro-phenylamino)-4H-1,3-thiazine[6,5-b]indole in A2780cis cells.
Solárová Z; Kello M; Varinská L; Budovská M; Solár P
Biomed Pharmacother; 2017 Jan; 85():463-471. PubMed ID: 27887849
[TBL] [Abstract][Full Text] [Related]
26. Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis.
Annamalai B; Liu X; Gopal U; Isaacs JS
Mol Cancer Res; 2009 Jul; 7(7):1021-32. PubMed ID: 19567782
[TBL] [Abstract][Full Text] [Related]
27. Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin.
Bull EE; Dote H; Brady KJ; Burgan WE; Carter DJ; Cerra MA; Oswald KA; Hollingshead MG; Camphausen K; Tofilon PJ
Clin Cancer Res; 2004 Dec; 10(23):8077-84. PubMed ID: 15585643
[TBL] [Abstract][Full Text] [Related]
28. Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib.
Leow CC; Chesebrough J; Coffman KT; Fazenbaker CA; Gooya J; Weng D; Coats S; Jackson D; Jallal B; Chang Y
Mol Cancer Ther; 2009 Aug; 8(8):2131-41. PubMed ID: 19671750
[TBL] [Abstract][Full Text] [Related]
29. Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.
Bruckheimer EM; Fazenbaker CA; Gallagher S; Mulgrew K; Fuhrmann S; Coffman KT; Walsh W; Ready S; Cook K; Damschroder M; Kinch M; Kiener PA; Woods R; Gao C; Dall'Acqua W; Wu H; Coats S
Neoplasia; 2009 Jun; 11(6):509-17, 2 p following 517. PubMed ID: 19484140
[TBL] [Abstract][Full Text] [Related]
30. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
31. Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
Ono N; Yamazaki T; Nakanishi Y; Fujii T; Sakata K; Tachibana Y; Suda A; Hada K; Miura T; Sato S; Saitoh R; Nakano K; Tsukuda T; Mio T; Ishii N; Kondoh O; Aoki Y
Cancer Sci; 2012 Feb; 103(2):342-9. PubMed ID: 22050138
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives.
Fukuyo Y; Inoue M; Nakajima T; Higashikubo R; Horikoshi NT; Hunt C; Usheva A; Freeman ML; Horikoshi N
Cancer Res; 2008 Aug; 68(15):6324-30. PubMed ID: 18676857
[TBL] [Abstract][Full Text] [Related]
33. Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct.
Hammond SA; Lutterbuese R; Roff S; Lutterbuese P; Schlereth B; Bruckheimer E; Kinch MS; Coats S; Baeuerle PA; Kufer P; Kiener PA
Cancer Res; 2007 Apr; 67(8):3927-35. PubMed ID: 17440108
[TBL] [Abstract][Full Text] [Related]
34. HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis.
Madrigal-Matute J; Fernandez-Garcia CE; Gomez-Guerrero C; Lopez-Franco O; Muñoz-Garcia B; Egido J; Blanco-Colio LM; Martin-Ventura JL
Cardiovasc Res; 2012 Jul; 95(1):116-23. PubMed ID: 22547655
[TBL] [Abstract][Full Text] [Related]
35. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
36. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
[TBL] [Abstract][Full Text] [Related]
37. Combined inhibition of Hsp90 and the proteasome affects NSCLC proteostasis and attenuates cell migration.
Zismanov V; Drucker L; Gottfried M
Anticancer Drugs; 2014 Oct; 25(9):998-1006. PubMed ID: 25153785
[TBL] [Abstract][Full Text] [Related]
38. Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells.
Bae J; Munshi A; Li C; Samur M; Prabhala R; Mitsiades C; Anderson KC; Munshi NC
J Immunol; 2013 Feb; 190(3):1360-71. PubMed ID: 23293352
[TBL] [Abstract][Full Text] [Related]
39. Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transition.
Huang Z; Zhou X; He Y; Ke X; Wen Y; Zou F; Chen X
Sci Rep; 2016 Dec; 6():38072. PubMed ID: 27909289
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.
Ayrault O; Godeny MD; Dillon C; Zindy F; Fitzgerald P; Roussel MF; Beere HM
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17037-42. PubMed ID: 19805107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]